Hemangioblastoma — Trials

Hemangioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00330564	Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow	terminated	Phase 2	15	M.D. Anderson Cancer CenterOTHER	1	Jun 27, 2024	clinicaltrials
NCT01015300	Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease	terminated	Early Phase 1	1	Dartmouth-Hitchcock Medical CenterOTHER	1	May 11, 2012	clinicaltrials

Data updated 22 days agoSource updated Jun 27, 2024source: clinicaltrials